Back
Ligand Pharmaceuticals Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
45
LGND
Ligand Pharmaceuticals
Last Price:
$105.11
Seasonality Move:
7.17%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Ligand Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 22% based on the past 30 years of stock performance.
-
Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Ligand Pharmaceuticals Stock Undervalued?The current Ligand Pharmaceuticals [LGND] share price is $104.97. The Score for LGND is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ligand Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 22% based on the past 30 years of stock performance.
Ligand Pharmaceuticals Stock Rating
Sell
45
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals overpriced?
-
Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Ligand Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com
52-Week Data
52-Week High:
129.90
52-Week Low:
67.72
Prediction Charts
Market Cap:
2B
Price in USD:
104.97
Volume:
105.1K
Beta:
1.45
Technical Analysis
SMA50:
110.69
SMA100:
112.99
SMA200:
108.22
52-Wk Change:
33.09%
Stock Predictions
-
Is Ligand Pharmaceuticals stock public?Yes, Ligand Pharmaceuticals is a publicly traded company.
-
What is the Ligand Pharmaceuticals stock quote today?The Ligand Pharmaceuticals stock price is 104.97 USD today.
-
How to buy Ligand Pharmaceuticals stock online?You can buy Ligand Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-31 | 105.55 | 104.98 | 106.37 | 103.06 |
| Apr-1 | 104.95 | 104.82 | 107.49 | 102.50 |
| Apr-2 | 102.60 | 108.73 | 108.77 | 102.60 |
| Apr-3 | 103.16 | 103.15 | 106.63 | 101.73 |
| Apr-4 | 99.17 | 99.52 | 101.15 | 96.76 |
| Apr-7 | 94.56 | 99.23 | 102.55 | 94.00 |
| Apr-8 | 102.00 | 96.67 | 102.70 | 94.77 |
| Apr-9 | 95.24 | 104.01 | 106.35 | 93.58 |
| Apr-10 | 104.60 | 101.39 | 104.86 | 97.48 |
| Apr-11 | 101.60 | 104.27 | 105.11 | 100.74 |
| Apr-14 | 104.07 | 106.59 | 107.62 | 100.30 |
| Apr-15 | 106.06 | 106.80 | 107.27 | 104.00 |
| Apr-16 | 106.59 | 104.62 | 106.59 | 102.64 |
| Apr-17 | 104.24 | 104.97 | 106.00 | 101.24 |
Ligand Pharmaceuticals Earnings
Ligand Pharmaceuticals Earnings Report: Per Share Ligand Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ligand Pharmaceuticals Forecast Revenue Growth
Ligand Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.33 per share, an increase this year of $0.45 per share, and an increase next year of $0.84 per share.
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.